| abstract |
The application provides a compound represented by Formula I and a pharmaceutically acceptable salt thereof: Formula I Where Substituents are as disclosed herein. The compounds and pharmaceutical compositions containing them are useful for the treatment of metabolic diseases and disorders such as type II diabetes. |